ClinicalTrials.gg

Neoplasms clinical trials

The registry lists 10,826 studies for Neoplasms across more than 10 countries. 2,322 are recruiting or about to start. 5,799 of them are mainly about Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16. Counting its 377 narrower conditions too, such as Breast Neoplasms: 113,224 studies, 27,682 open.

ClinicalTrials.gov finds 124,774 studies for Neoplasms. How that becomes 10,824 here

This page counts the studies the registry files under Neoplasms, and those it files under no condition that list Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count

  1. 124,774Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −100,285Filed under a narrower condition, counted on its own pageBreast Neoplasms 12,831 · Carcinoma, Non-Small-Cell Lung 6,351 · Prostatic Neoplasms 5,600 · Colorectal Neoplasms 4,993 · Multiple Myeloma 3,387 · Leukemia, Myeloid, Acute 3,124 · 339 more
  3. −7,143List Neoplasms as a condition, but the registry did not file them under itMost often written as “Advanced Solid Tumors” (534), “Solid Tumor” (495), and “Unspecified Adult Solid Tumor, Protocol Specific” (461). The registry filed 5,401 of them under no condition at all, and the others under other conditions only, most often Cancer Pain (131) and Myeloproliferative Disorders (95).
  4. −6,522Match it another way4,306 name it in the title, 457 in a keyword, and 1,759 by a synonym or other text the search reads.
  5. 10,824The count on this page

Status

Completed
5,538
Recruiting
1,718
Terminated
1,019
Status unknown
939
Active, not recruiting
599
Not yet recruiting
498

Phase

Phase 1
2,627
Phase 2
1,981
Phase 3
656
Phase 4
205
Early Phase 1
122

Where

United States
4,949
France
1,207
United Kingdom
833
Canada
827
China
754
Spain
714

What is being tested here

Drugs under test in Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Immune checkpoint inhibitors 69 open · Tyrosine kinase inhibitors (TKIs) 41 open · Antimetabolites 20 open · Angiogenesis inhibitors 15 open · PARP inhibitors 15 open

Coming up

855studies finish main data collection within a year41 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 1,718 Neoplasms studies recruiting now, 1,173 (68%) set no upper age limit and 333 (19%) stop at 75 or younger. 337 (20%) take children under 18. 90 (5%) are for women only and 35 (2%) for men only; 228 (13%) take healthy volunteers.

Recruiting studies that take each age, of 1,718
AgeWomenMen
10263 (15%)257 (15%)
181,497 (87%)1,465 (85%)
301,468 (85%)1,419 (83%)
401,464 (85%)1,415 (82%)
501,468 (85%)1,425 (83%)
651,485 (86%)1,439 (84%)
751,444 (84%)1,404 (82%)
851,286 (75%)1,252 (73%)

Across all 10,826 studies, recruiting or not: 18% stop at 75 or younger and 12% at 65; 17% take children; 7% are for women only and 3% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neoplasms studies take

Of 904 phase 1 interventional studies under Neoplasms, half reached primary completion within 40 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 140 mo23–64 · 904 studies38 mo22–62 · 677 studies48 mo28–88 · 227 studies
Phase 1/260 mo39–89 · 297 studies61 mo41–88 · 195 studies59 mo33–111 · 102 studies
Phase 252 mo33–92 · 514 studies42 mo26–68 · 179 studies58 mo36–99 · 335 studies
Phase 2/344 mo28–90 · 47 studies——
Phase 350 mo33–84 · 202 studies44 mo30–72 · 119 studies60 mo43–96 · 83 studies
Phase 438 mo21–64 · 88 studies—33 mo21–56 · 64 studies
Interventional, no phase29 mo13–52 · 2,061 studies23 mo11–53 · 75 studies29 mo13–52 · 1,986 studies
Observational58 mo24–210 · 1,246 studies47 mo29–102 · 148 studies61 mo24–227 · 1,098 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting24

Show 19 more

Newly registered48

Show 43 more

Studies

Recruiting first, then most recently updated. Showing 50 of 10,826. Browse all 10,826 → or search them.